Bringing RWE Upstream: Using AI & Real-World Data to Accelerate Early Clinical Development Decisions

• Explore how RWE can move beyond traditional pre- and post-launch applications to support earlier decisions around patient selection, tumour selection, biomarkers and trial design
• Lessons from pilots on how AI and advanced analytics can enable rapid feasibility insights and analysis of large, complex datasets and where traditional statistical approaches remain more effective
• Navigate the organisational change, cross-functional education and governance needed to embed RWE and AI into early development

Speakers:

Aliki Taylor

Head Executive Director, Rwe TA Oncology

Gilead Sciences